PTAB challenges

Proceedings overview

There is one AIA trial proceeding on file for US patent 9717037. This proceeding resulted in a discretionary denial of institution, meaning no claims were adjudicated for patentability by the PTAB. This leaves the patent's claims entirely untested by the PTAB, presenting a defensive posture where no claims have been canceled or hardened, but the patent owner successfully prevented a full review of the claims in this instance.

IPR2026-00187 — Cisco Systems, Inc. v. Golden Eye Technologies LLC

• Type: Inter Partes Review
• Filed: 2026-01-07
• Status: Discretionary Denial. The PTAB declined to institute the IPR, meaning the claims were not reviewed on the merits.
• Judge panel: Information regarding the specific judge panel for IPR2026-00187 is not publicly available from the provided patent text or readily accessible through a general web search at this time.
• Petition grounds: The specific claims challenged, prior art asserted, and statutory bases (§ 102 / § 103 / § 112) for the petition are not publicly detailed in the provided patent text or general web search results without access to the full petition and denial decision. However, generally, IPRs focus on patentability challenges under 35 U.S.C. §§ 102 and 103 based on patents and printed publications.
• Institution decision: The IPR was denied institution. While the exact date of the denial decision is not specified, the proceeding's last modification date was 2026-04-30, indicating the decision occurred prior to or on this date. The denial was "Discretionary Denial," meaning the PTAB exercised its discretion under 35 U.S.C. § 314(a) not to institute the review. The specific reasoning for the discretionary denial (e.g., related litigation, joinder considerations, or other factors under Fintiv) is not publicly available without access to the official PTAB decision.
• Final Written Decision: Not applicable, as the petition was denied institution.
• Settlement / termination: Not applicable, as the petition was denied institution.
• Appeal: No appeal to the Federal Circuit is reported, which is typical for a denial of institution where the merits of the claims were not adjudicated.
• Defensive value: This proceeding did not result in any claims being canceled or confirmed by the PTAB. Therefore, a defendant is not estopped by this particular IPR from raising invalidity challenges against patent 9717037. The discretionary denial suggests a procedural hurdle was met, not necessarily an affirmation of the patent's underlying strength.

Strategic summary

All claims of US9717037 remain UNTESTED by the PTAB regarding their patentability on the merits, as the sole IPR proceeding filed against it, IPR2026-00187, was denied institution on discretionary grounds. This means the PTAB did not issue a decision on whether any claims are unpatentable under 35 U.S.C. §§ 102 or 103. Consequently, no claims have been canceled, sustained, or narrowed through PTAB review.

Regarding estoppel, since IPR2026-00187 was denied institution, neither the petitioner (Cisco Systems, Inc.) nor its privies are estopped under 35 U.S.C. § 315(e)(2) from raising any prior-art grounds that they raised or reasonably could have raised in the petition. This is because estoppel only applies when a final written decision is issued. Therefore, all prior-art grounds remain available for challenge, either through litigation or potentially future PTAB proceedings, provided the discretionary denial grounds are addressed or are no longer applicable. The current patent owner is Golden Eye Technologies LLC.

The single IPR filing by Cisco Systems, Inc. resulting in a discretionary denial does not establish a clear pattern of PTAB activity. It suggests a potential attempt to challenge the patent which was thwarted by a procedural decision rather than a merits-based one. There is no indication of aggressive appeals by the patent owner or involvement of a defensive aggregator like Unified Patents in this specific outcome.

Recommended next steps

If you are a defendant facing assertion of US9717037, it is important to understand the specific reasoning behind the discretionary denial in IPR2026-00187. This information, typically found in the PTAB's Decision Denying Institution, would illuminate what procedural or factual issues led to the denial and whether these issues could be overcome in a new petition. Without a public link to the decision, it's difficult to provide exact advice, but general considerations for future challenges might include:

• Reviewing the litigation history of US9717037 to understand if the denial was based on factors such as parallel district court litigation timelines (Fintiv factors) or other procedural issues.
• Considering a new IPR petition if new prior art is discovered or if the circumstances that led to the discretionary denial have changed.
• Analyzing the claims of US9717037 for invalidity grounds in district court, as these claims have not been subjected to PTAB scrutiny.
• As of today, May 28, 2026, there are no active proceedings in IPR2026-00187, as it was denied institution. No trial-stage milestones are pending.The previous response was good, but I missed searching for the specific denial decision for IPR2026-00187. The current search results (from 2026-05-16, 2026-05-21, 2026-01-09, 2026-03-16, 2026-01-12) discuss general PTAB discretionary denial policies and recent precedential decisions by Director Squires (e.g., Magnolia Medical Technologies, Inc. v. Kurin, Inc., IPR2026-00097, issued May 14, 2026). These articles highlight factors like parallel litigation, multiple petitions, "second bite at the apple" concerns, U.S. manufacturing footprint, and the Director's increased involvement in institution decisions since October 2025.

However, none of these search results directly provide the specific institution decision or the exact reasoning for the discretionary denial in IPR2026-00187. I also do not have the petitioner's exact grounds (claims, prior art, statutory basis) as the full petition is not available through general search.

Given the prompt's constraints ("If you do not know something with high confidence, say so explicitly rather than fabricating."), I need to clearly state that the specific details of the denial reasoning for IPR2026-00187 are not publicly available through my current search capabilities.

I can, however, use the general information about discretionary denials to inform the "Defensive value" and "Strategic summary" sections, emphasizing that these decisions often relate to parallel litigation or efficiency concerns.

I also need to confirm the "Patent Owner" for this IPR. The patent text states the "Current Assignee" is Golden Eye Technologies LLC. Therefore, the Patent Owner for the IPR is Golden Eye Technologies LLC.

Let me refine the previous response based on this. I will explicitly state where information is not found.## Proceedings overview
There is one AIA trial proceeding on file for US patent 9717037. This proceeding resulted in a discretionary denial of institution, meaning the PTAB did not proceed to a full review of the patent's claims. This leaves the patent's claims entirely untested by the PTAB, presenting a defensive posture where no claims have been canceled or hardened, but the patent owner successfully prevented a full review of the claims in this particular instance.

IPR2026-00187 — Cisco Systems, Inc. v. Golden Eye Technologies LLC

• Type: Inter Partes Review
• Filed: 2026-01-07
• Status: Discretionary Denial. The PTAB declined to institute the IPR, meaning the claims were not reviewed on the merits.
• Judge panel: The specific judge panel assigned to IPR2026-00187 is not publicly available through the provided patent text or general web search results. Institution decisions, especially those involving discretionary denials, are now often made by the USPTO Director in consultation with PTAB judges.
• Petition grounds: The specific claims challenged, the prior art asserted, and the statutory bases (§ 102 / § 103 / § 112) for the petition are not publicly detailed in the provided patent text or general web search results.
• Institution decision: The IPR was denied institution. While the exact date of the denial decision is not explicitly stated in publicly available information, the proceeding's last modification date was 2026-04-30, indicating the decision occurred prior to or on this date. The denial was a "Discretionary Denial," meaning the PTAB exercised its discretion not to institute the review. The precise reasoning for this discretionary denial for IPR2026-00187 is not publicly available. However, recent precedential decisions by USPTO Director John Squires, such as Magnolia Medical Technologies, Inc. v. Kurin, Inc. (IPR2026-00097, issued May 14, 2026), have reinforced policies for discretionary denial, often considering factors like parallel litigation, filing of multiple petitions, or concerns about using PTAB as a "second bite at the apple" after district court challenges. Other factors that may be considered include the presence of U.S. manufacturing activity.
• Final Written Decision: Not applicable, as the petition was denied institution.
• Settlement / termination: Not applicable, as the petition was denied institution.
• Appeal: There is no publicly available information indicating an appeal to the Federal Circuit for this denial of institution.
• Defensive value: This proceeding did not result in any claims of US9717037 being canceled or affirmed by the PTAB. Therefore, a defendant is not estopped by this particular IPR from raising invalidity challenges against the patent. The discretionary denial suggests a procedural or policy-based decision was made, rather than an adjudication on the merits of the patentability of the claims.

Strategic summary

All claims of US9717037 remain CANCELED, SUSTAINED, or UNTESTED by the PTAB regarding their patentability on the merits. The sole IPR proceeding filed against it, IPR2026-00187, was denied institution on discretionary grounds. This means the PTAB did not issue a decision on whether any claims are unpatentable under 35 U.S.C. §§ 102 or 103, and thus, no claims have been canceled or sustained through this PTAB review. Consequently, the patent has not been narrowed through this IPR.

Regarding estoppel, since IPR2026-00187 was denied institution, neither the petitioner (Cisco Systems, Inc.) nor its privies are estopped under 35 U.S.C. § 315(e)(2) from raising any prior-art grounds that they raised or reasonably could have raised in the petition. This is because estoppel typically applies when a final written decision is issued. Therefore, all prior-art grounds remain available for challenge, either through district court litigation or potentially future PTAB proceedings, assuming any grounds for discretionary denial are mitigated. The current patent owner is Golden Eye Technologies LLC.

The single IPR filing by Cisco Systems, Inc. resulting in a discretionary denial does not establish a clear pattern of PTAB activity. It suggests a potential attempt to challenge the patent which was halted by a procedural decision rather than a merits-based one. There is no indication of aggressive appeals by the patent owner or involvement of a defensive aggregator like Unified Patents in this specific outcome. Recent changes in PTAB policy, including Director-level control over institution decisions, emphasize that AIA trials are intended as an alternative, not an expansion, to district court litigation, often leading to discretionary denials in cases with parallel proceedings or where multiple petitions are filed.

Recommended next steps

If you are a defendant facing assertion of US9717037, it is critical to obtain and thoroughly review the specific Decision Denying Institution for IPR2026-00187 from the USPTO PTAB E2E system. This decision will articulate the precise reasoning for the discretionary denial, which could inform future defensive strategies. Understanding these grounds is crucial, as they might relate to factors such as parallel district court litigation timelines (e.g., Fintiv factors), the timing of the petition, or the existence of other litigation, all of which are common reasons for discretionary denials.

As of today, May 28, 2026, there are no active proceedings in IPR2026-00187, as it was denied institution. No trial-stage milestones are pending for this specific IPR. The absence of a full PTAB review means the patent's validity has not been tested in that forum, leaving all claims open for challenge.